Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (1601)	4/25/1998 10:13:00 AM
From: James Baker	Respond to of 9523

Jman: Listed below is how a urologist (and PFEr) answered a similar question on AOL's Motley Fool Pfizer Board. Hope this helps, BigKNY3>>>>>>>>>>>>>> And I will repeat my very first response to hilm on AOL that I think from he own statements he shows such disrespect for MUSE and poor education about the use, appropriate dose (ie no one starts at lowest level any more) etc that of course it is doomed to failure in his patient population. The published P-N paper in the NEJM showed 65% success for MUSE with largely mod to severe ED patients. If a doc is not seeing this success in general ED pts we have to ask what is the doc doing as much as what is the medication doing? Jim